Total number of projects: 6
As coordinator: 1
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.2*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 2.999.529 | 16.941.213 | 988.350 | 1 | 2 | |
2011 | 0 | 8.991.407 | 548.238 | 2 | ||
2010 | 0 | 11.187.685 | 78.705 | 1 |
Total number of partners: 1866
Partner loyalty:
Frequent Partner: (> 2 projects): 968
Rare Partner: 898
Frequent / Rare Partner Ratio: 1.08
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-02-01 | European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | EuroHYP-1 | participant | 10.941.665 | 38 |
2012-01-01 | VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial | DO-HEALTH | participant | 5.999.548 | 24 |
2012-01-01 | OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma | OPTATIO | coordinator | 2.999.529 | 12 |
2011-10-01 | Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities | EpoCan | participant | 2.995.104 | 13 |
2011-08-01 | EUROpean consortium for antiCALINs as next generation high-affinity protein therapeutics | EUROCALIN | participant | 5.996.304 | 11 |
2010-02-01 | OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) | OPTiMiSE | participant | 11.187.685 | 23 |